- Home
- INMB vs FULC Comparison
INMB vs FULC Comparison
Compare INMB & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- FULC
- Stock Information
- Founded
- INMB 2015
- FULC 2015
- Country
- INMB United States
- FULC United States
- Employees
- INMB N/A
- FULC N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- INMB Health Care
- FULC Health Care
- Exchange
- INMB Nasdaq
- FULC Nasdaq
- Market Cap
- INMB 176.5M
- FULC N/A
- IPO Year
- INMB 2019
- FULC 2019
- Fundamental
- Price
- INMB $7.09
- FULC $5.41
- Analyst Decision
- INMB Strong Buy
- FULC Hold
- Analyst Count
- INMB 3
- FULC 8
- Target Price
- INMB $24.33
- FULC $6.57
- AVG Volume (30 Days)
- INMB 225.9K
- FULC 665.5K
- Earning Date
- INMB 05-08-2025
- FULC 05-01-2025
- Dividend Yield
- INMB N/A
- FULC N/A
- EPS Growth
- INMB N/A
- FULC N/A
- EPS
- INMB N/A
- FULC N/A
- Revenue
- INMB $14,000.00
- FULC $80,000,000.00
- Revenue This Year
- INMB N/A
- FULC N/A
- Revenue Next Year
- INMB N/A
- FULC N/A
- P/E Ratio
- INMB N/A
- FULC N/A
- Revenue Growth
- INMB N/A
- FULC 3087.25
- 52 Week Low
- INMB $4.32
- FULC $2.32
- 52 Week High
- INMB $11.76
- FULC $10.13
- Technical
- Relative Strength Index (RSI)
- INMB 41.97
- FULC 72.71
- Support Level
- INMB $6.98
- FULC $4.78
- Resistance Level
- INMB $8.00
- FULC $5.75
- Average True Range (ATR)
- INMB 0.45
- FULC 0.54
- MACD
- INMB -0.06
- FULC 0.20
- Stochastic Oscillator
- INMB 6.51
- FULC 75.17
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.